Elevated serum iron levels following administration of cisplatinum.

Abstract:

:An increase in serum iron levels and a decrease in serum unsaturated iron binding capacity (uIBC) were noted following the administration of cisplatinum to 9 children with malignancies. The mean serum iron concentration increased from a pretreatment level of 75.7 +/- 30.5 micrograms/ml to a posttreatment level of 162.1 +/- 65.3 micrograms/ml with the first cisplatinum treatment course (p less than 0.004). The uIBC concomitantly decreased from 181.9 +/- 33.7 micrograms/ml to 86.4 +/- 44.6 micrograms/ml (p less than 0.0005). A cumulative effect was noted following subsequent courses. The levels returned to baseline values within 2-4 months following cessation of therapy in 6 children in whom follow-up data were available. It is possible that this reversal of the iron/uIBC ratio is the result of cisplatinum competition for iron binding sites to proteins.

journal_name

Oncology

journal_title

Oncology

authors

Kletter G,Parks BR Jr,Bhatnagar A,Iyer RV

doi

10.1159/000226657

subject

Has Abstract

pub_date

1988-01-01 00:00:00

pages

421-3

issue

6

eissn

0030-2414

issn

1423-0232

journal_volume

45

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Tumor-associated antigen of spontaneous mammary tumor in rats.

    abstract::The present study was undertaken to detect the spontaneous mammary tumor-associated antigen ( MTAA ), and to find the cross-reacting antigen in chemically-induced mammary tumor. The antisera against spontaneous mammary tumor were raised in the WAF1 rats of the same strain and tested for the detection of tumor-associat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225824

    authors: Imamura N,Yanagihara K,Kusunoki Y

    更新日期:1984-01-01 00:00:00

  • Relapse of Hodgkin's disease after ten years.

    abstract::We report four cases of Hodgkin's disease (HD) relapsing after complete remission for over a 10-year period after the initial therapy. Three of the patients had mixed-cellularity subtypes as a primary histological diagnosis, and the rebiopsies demonstrated mixed cellularity in all very late relapse cases. Two patients...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227474

    authors: Illés A,Bányai A,Vadász G,Szegedi G

    更新日期:1995-07-01 00:00:00

  • Carboplatin in the treatment of non-small cell lung cancer: a review.

    abstract::Cisplatin is among the most active agents available for the therapy of non-small cell lung cancer (NSCLC). Its congener, carboplatin, has been the focus of intense clinical trials over the last several years because of its improved therapeutic index. Results from randomized trials have shown that carboplatin is active...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227259

    authors: Comis RL

    更新日期:1993-11-01 00:00:00

  • Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer.

    abstract:OBJECTIVE:It was the aim of our study to evaluate the efficacy and safety of weekly topotecan in patients with advanced or recurrent cervical disease. METHODS:Topotecan was administered intravenously as a weekly infusion at a dose of 3.5 mg/m(2) on days 1, 8 and 15 of a 28-day cycle. After the second cycle, the dose w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000330537

    authors: Lorusso D,Mainenti S,Pietragalla A,Fusco E,Malaguti P,Masciullo V,Scambia G

    更新日期:2011-01-01 00:00:00

  • Companion diagnostics in oncology - current status and future aspects.

    abstract::A large number of targeted anticancer drugs are currently under development and most of them will have a companion diagnostic linked to their use. If a diagnostic assay is developed in conjunction with a targeted anticancer drug, such an assay will later end up determining the conditions for the use of the drug after ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000353454

    authors: Jørgensen JT

    更新日期:2013-01-01 00:00:00

  • Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

    abstract:OBJECTIVES:Our aim was to assess FDG-PET/CT as a surrogate biomarker of the pathological complete response in locally advanced rectal cancer treated with neoadjuvant chemoradiation. METHODS:T3-4 and/or N+ rectal cancer patients were treated prospectively with capecitabine-based chemoradiation and total mesorectal exci...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000345601

    authors: Bampo C,Alessi A,Fantini S,Bertarelli G,de Braud F,Bombardieri E,Valvo F,Crippa F,Di Bartolomeo M,Mariani L,Milione M,Biondani P,Avuzzi B,Chiruzzi C,Pietrantonio F

    更新日期:2013-01-01 00:00:00

  • Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.

    abstract:OBJECTIVES:Low body mass index (BMI) and/or low lean body mass have been shown to be risk factors for chemotherapy-related toxicities in a number of different cancers. However, no data are available regarding the role of BMI as a risk factor for developing toxicities related to the novel anticancer agent, trabectedin, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000487266

    authors: Vincenzi B,Badalamenti G,Armento G,Silletta M,Spalato Ceruso M,Catania G,Napolitano A,Maltese G,Valeri S,Incorvaia L,Santini D,Tonini G

    更新日期:2018-01-01 00:00:00

  • Phase II study of UFT plus leucovorin in colorectal cancer.

    abstract::The activity and toxicity of UFT (Tegafur and Uracil) in a 4:1 molar concentration, plus leucovorin (LV), were evaluated in the treatment of 45 patients with advanced, bidimensionally measurable metastatic colorectal carcinoma. Initially 350 and later 300 mg/m2/day, plus 150 mg LV, as administered in divided doses eve...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227741

    authors: Pazdur R

    更新日期:1997-01-01 00:00:00

  • Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

    abstract:OBJECTIVE:An increasing number of patients with advanced pancreatic or biliary tract cancer who progress after a gemcitabine-containing regimen are candidates for further chemotherapy. We therefore evaluated a fully oral regimen of capecitabine and celecoxib (CapCel) as second-line treatment in these patients. METHODS...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000205388

    authors: Pino MS,Milella M,Gelibter A,Sperduti I,De Marco S,Nuzzo C,Bria E,Carpanese L,Ruggeri EM,Carlini P,Cognetti F

    更新日期:2009-01-01 00:00:00

  • Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers.

    abstract::Novel human estrogen receptor (ER)-beta was identified in cDNA libraries from human testis. ER-beta specifically expresses in testis, ovary, thymus, spleen, osteoblasts and fetus. ER-beta might not conserve the same physiological functions as does ER-alpha. Therefore, the clinical significance of the expression of ER-...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012121

    authors: Fujimoto J,Hirose R,Sakaguchi H,Tamaya T

    更新日期:2000-05-01 00:00:00

  • A phase II trial of vindesine in hepatocellular cancer.

    abstract::Sixteen patients with histologically confirmed inoperable hepatocellular carcinoma were treated with vindesine 3 mg/m2 i.v. weekly. Anemia, leukopenia and neuritis were documented but no severe or life-threatening toxicity was seen. There were no objective responses among the 14 evaluable patients. Eight had a no chan...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227434

    authors: Falkson G,Burger W

    更新日期:1995-01-01 00:00:00

  • Chemo-radiotherapy of lung metastases of testicular tumors.

    abstract::We studied the chemo-radiotherapy of testicular tumors in clinical stage III. Our study involved 54 patients with lung metastases of seminoma and nonseminoma, treated with a combination of radiotherapy and chemotherapy. The results obtained have not satisfied our expectations. While in the 16 seminoma patients only 43...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225493

    authors: Mechl Z,Malír A

    更新日期:1980-01-01 00:00:00

  • Models, mechanisms and management of anticipatory nausea and emesis.

    abstract::Anticipatory nausea and vomiting (ANV) are learned responses to chemotherapy that develop in up to 25% of patients by the fourth treatment cycle. Post-treatment nausea and emesis must occur before development of ANV can take place. Certain patient characteristics and other responses to chemotherapy can also be used to...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227633

    authors: Morrow GR,Rosenthal SN

    更新日期:1996-06-01 00:00:00

  • Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.

    abstract:OBJECTIVE:Tyrosine kinase B (TrkB) is associated with aggressive behavior and poor prognosis in various cancers. Here we examined the association between TrkB expression and distant metastases/prognosis in gastric carcinoma (GC). PATIENTS AND METHODS:We analyzed TrkB expression in 161 GC patients by immunohistochemist...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151615

    authors: Zhang Y,Fujiwara Y,Doki Y,Takiguchi S,Yasuda T,Miyata H,Yamazaki M,Ngan CY,Yamamoto H,Ma Q,Monden M

    更新日期:2008-01-01 00:00:00

  • Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.

    abstract:INTRODUCTION:Because the frequency of bile duct invasion in hepatocellular carcinoma (HCC) patients is very rare, there is limited clinical evidence to demonstrate the outcomes of systemic therapy in HCC with bile duct invasion. OBJECTIVE:Our aim was to clarify the efficacy and safety of sorafenib treatment in patient...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507051

    authors: Tanaka T,Kuzuya T,Ishigami M,Ito T,Ishizu Y,Honda T,Ishikawa T,Fujishiro M

    更新日期:2020-01-01 00:00:00

  • Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.

    abstract:INTRODUCTION:Carcinoma of the biliary system is a rare tumor entity, and patients with advanced disease face a dismal prognosis. Because of the absence of standard chemotherapy for advanced biliary carcinoma, we have performed two consecutive studies to evaluate the clinical potential of 5-fluorouracil, leucovorin and ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000011961

    authors: Raderer M,Hejna MH,Valencak JB,Kornek GV,Weinländer GS,Bareck E,Lenauer J,Brodowicz T,Lang F,Scheithauer W

    更新日期:1999-04-01 00:00:00

  • Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.

    abstract::The expression of cyclin-dependent kinase 1 (cdc2), cyclin A and cyclin B1 was immunohistochemically studied in 101 hepatocellular carcinomas (HCC). cdc2 overexpression was directly related to advanced stage, portal invasion, intrahepatic metastasis, poor differentiation, high alpha-fetoprotein level, large size, high...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012140

    authors: Ito Y,Takeda T,Sakon M,Monden M,Tsujimoto M,Matsuura N

    更新日期:2000-06-01 00:00:00

  • Lethal exitus of a patient with N-nitrosodimethylamine poisoning, 2.5 years following the first ingestion and signs of intoxication.

    abstract::The report describes the lethal exitus of a 44-year-old woman after repeated criminal poisoning with N-nitrosodimethylamine. She died 32 months following the initial symptoms and developed a liver cirrhosis with multiple bleeding, a hemolytic syndrome and diabetes mellitus. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225451

    authors: Fussgaenger RD,Ditschuneit H

    更新日期:1980-01-01 00:00:00

  • Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.

    abstract:BACKGROUND:Clinical significance of immunohistochemically detectable level of p53 protein has been reported, but with some limitation as a prognosticator of bladder cancer patients. Whether or not simultaneous evaluation of mdm2 and p53 expression in bladder cancer exceed the prognostic significance of conventional his...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011971

    authors: Shiina H,Igawa M,Shigeno K,Yamasaki Y,Urakami S,Yoneda T,Wada Y,Honda S,Nagasaki M

    更新日期:1999-04-01 00:00:00

  • Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.

    abstract::We investigated the effects of piroxicam, a cyclooxygenase inhibitor, and esculetin, a lipoxygenase inhibitor, on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female rats. Seven days after receiving a 5-mg dose of DMBA, rats were fed either a high-fat (20% soybean oil) or low-fat (0.5% soybe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227374

    authors: Kitagawa H,Noguchi M

    更新日期:1994-09-01 00:00:00

  • Evaluation of carcinoembryonic antigen levels in gastric juice, stomach mucosa and plasma in high-risk and gastric cancer patients.

    abstract::The aim of this study is to compare the levels of carcinoembryonic antigen (CEA) in the gastric juice, stomach mucosa and plasma of gastrectomy patients at risk of developing cancer with those in normal controls and gastric cancer subjects. Blood samples, gastric juices and biopsy material were taken from 52 patients ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226354

    authors: Castelli M,Guadagni S,Bagnato A,Pistoia MA,Carboni M,Sega E

    更新日期:1986-01-01 00:00:00

  • Radioimmunoimaging in malignant melanoma with monoclonal antibodies.

    abstract::Twenty-five patients with cutaneous melanoma were imaged with F(ab')2 fragments of antimelanoma monoclonal antibody (MoAb) 225.28S labeled with 99mTc and 131I or 111In. Out of 16 patients without evidence of metastatic lesions, 6 false-positive cases were observed. Only 4 out of 9 patients with known lesions showed po...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226649

    authors: Repetto L,Scopinaro G,Michelotti A,Claudiani F,Fusco V,Grimaldi A,Sertoli MR,Rosso R

    更新日期:1988-01-01 00:00:00

  • Bone scintigrams: their clinical usefulness in patients with breast carcinoma.

    abstract::A comparison of bone scintigrams and roentgenographic skeletal surveys, obtained on 170 patients with breast carcinoma, was made to evaluate the diagnostic efficacy of these techniques in detecting metastatic bone lesions. The bone scans were abnormal in 81 patients, while the roentgenograms were abnormal in only 51. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225325

    authors: Joo KG,Parthasarathy KL,Bakshi SP,Rosner D

    更新日期:1979-01-01 00:00:00

  • Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701).

    abstract:OBJECTIVE:This phase II study examined the efficacy and safety of alternating regimens of mFOLFOX6 and FOLFIRI as a first-line treatment for unresectable or metastatic colorectal cancer. PATIENTS AND METHODS:Forty-eight patients were enrolled in this study. Patients received an alternating regimen of 4 cycles of mFOLF...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000346690

    authors: Oki E,Emi Y,Akagi Y,Tokunaga S,Sadanaga N,Tanaka T,Ogata Y,Saeki H,Kakeji Y,Baba H,Nishimaki T,Natsugoe S,Shirouzu K,Maehara Y,Kyushu Study Group of Clinical Cancer.

    更新日期:2013-01-01 00:00:00

  • Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.

    abstract::Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurable disease on entry into the study. No responses were observed while 3 patients,...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226836

    authors: Benedetti Panici P,Scambia G,Greggi S,Salerno G,Cento R,Mancuso S

    更新日期:1990-01-01 00:00:00

  • Sinophobic growth in oestrogen receptor-negative metastatic breast cancer.

    abstract::The mode of growth of tumour cells from primary breast carcinoma in the axillary nodes is shown to be related to the oestrogen receptor (ER) status of the primary tumour. ER-positive primaries are described as tending to show sinophilic growth, the tumour cells spreading along the nodal sinuses; while the ER-negative ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225735

    authors: Hartveit F,Thorsen T,Tangen M,Maehle BO,Thoresen S,Halvorsen JF

    更新日期:1983-01-01 00:00:00

  • Flow cytometric analysis of the DNA content of tumor cells in cases of gastric cancer in the upper third of the stomach and in the remnant stomach.

    abstract::Thirteen samples of gastric tumors that had developed in the remnant stomach (remnant gastric cancer) were compared with 63 samples of primary gastric tumors located in the upper third of the stomach (primary gastric cancer) by both clinicopathologic and flow cytometric analysis. The depths of invasion of all these tu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227441

    authors: Ikeguchi M,Kondou A,Oka A,Tsujitani S,Maeta M,Kaibara N

    更新日期:1995-03-01 00:00:00

  • Clinical staging of adult non-Hodgkin's lymphoma.

    abstract::In this study an attempt is made to propose a working clinical classification and staging of adult non-Hodgkin's lymphoma (NHL) which brings out both primary site and extent of disease. Unlike childhood NHL, where histopathology is uniformly of unfavourable type, this clinical staging system seems to have a prognostic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226843

    authors: Lalitha N

    更新日期:1990-01-01 00:00:00

  • Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis.

    abstract::The present communication reports the inhibitory action of aminoglutethimide on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinogenesis in virgin female Holtzman rats. When 20 mg of DMBA is given to the rats and maintained on normal diet for 32 weeks, approximately 70% of the animals develop mammary tum...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226013

    authors: Rao AR,Das MG,Das P

    更新日期:1985-01-01 00:00:00

  • Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.

    abstract::Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined in 8 patients with disseminated testicular carcinoma before, during and 1 year after termination of a combination chemotherapy with cis-diamminedichloroplatinum (CDDP). The decrease in median GFR in comparison with the pretreatment...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000225718

    authors: Meijer S,Mulder NH,Sleijfer DT,Donker AJ,Sluiter WJ,de Jong PE,Schraffordt Koops H,van der Hem GK

    更新日期:1983-01-01 00:00:00